Replies to post #41998 on Biotech Values

[DewDiligence]

>By chance would you happen to know the criteria for [Japanese] fast-track?<

I don’t know what the Japanese regs say about fast track, but I know it’s rare. With Roche’s Copegus, the MHLW virtually had to fast-track it because Pegasys was already approved.